APOA1 and fatty liver disease: These changes are due to the antioxidant effect of carotenoids and are also partially explained by the modulation of genes related to lipid metabolism and other metabolic pathways of fatty liver disease, particularly through the overexpression of ACOX1, APOA1 and NR1H2 (LXR) and the synthesis of these proteins.